Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Condensed N-heterocyclic compounds and their use as CRF receptor antagonists

Condensed N-heterocyclic compounds and their use as CRF receptor antagonists

US Patent 7427630 · Granted Sep 23, 2008

Estimated economic value: $3,338,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Antimicrobial compounds and methods2025
Oxalamido-substituted tricyclic inhibitors of hepatitis b virus2025
Spirocyclic inhibitors of hepatitis B virus2025
Substituted 2-azabicyclo[3.1.1]heptane and 2-azabicyclo[3.2.1]octane derivatives2023
Tricyclic inhibitors of Hepatitis B virus2022
Indazoles and azaindazoles as LRRK2 inhibitors2022
Process to produce a fermentation product2021
Process for propagating a yeast capable to ferment glucose and xylose2021
Process for preparing intermediates for the synthesis of optically active beta-a2021
Process for the preparation of a novel umeclidinium synthesis intermediate2021
Ultrafiltration for preparing outer membrane vesicles2017
Culture medium with yeast or soy bean extract as amino acid source and no protei2016